Avita Medical Inc (AVH) - Total Liabilities
Based on the latest financial reports, Avita Medical Inc (AVH) has total liabilities worth AU$69.39 Million AUD (≈ $49.10 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Avita Medical Inc - Total Liabilities Trend (1994–2025)
This chart illustrates how Avita Medical Inc's total liabilities have evolved over time, based on quarterly financial data. See working capital position of Avita Medical Inc to evaluate short-term liquidity relative to the company's equity base.
Avita Medical Inc Competitors by Total Liabilities
The table below lists competitors of Avita Medical Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Torimbia Socimi S.A.
MC:YTRM
|
Spain | €89.87 Million |
|
Eastern Water Resources Development and Management Public Company Limited
F:7ES1
|
Germany | €16.24 Billion |
|
Chaintech Technology Corp
TW:2425
|
Taiwan | NT$1.71 Billion |
|
Calida Holding AG
SW:CALN
|
Switzerland | CHF77.21 Million |
|
Captor Therapeutics S.A.
WAR:CTX
|
Poland | zł11.27 Million |
|
So-Young International Inc
NASDAQ:SY
|
USA | $852.81 Million |
|
Fractyl Health, Inc. Common Stock
NASDAQ:GUTS
|
USA | $111.94 Million |
|
Sunspring Metal Corp
TW:2062
|
Taiwan | NT$3.30 Billion |
Liability Composition Analysis (1994–2025)
This chart breaks down Avita Medical Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Avita Medical Inc stock valuation.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.57 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | 0.16 | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | -4.16 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 1.23 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Avita Medical Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Avita Medical Inc (1994–2025)
The table below shows the annual total liabilities of Avita Medical Inc from 1994 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-06-30 | AU$75.21 Million ≈ $53.22 Million |
+20.18% |
| 2024-06-30 | AU$62.58 Million ≈ $44.28 Million |
+215.04% |
| 2023-06-30 | AU$19.87 Million ≈ $14.06 Million |
+57.82% |
| 2022-06-30 | AU$12.59 Million ≈ $8.91 Million |
+25.11% |
| 2021-06-30 | AU$10.06 Million ≈ $7.12 Million |
-30.99% |
| 2020-06-30 | AU$14.58 Million ≈ $10.32 Million |
+199.57% |
| 2019-06-30 | AU$4.87 Million ≈ $3.44 Million |
+64.90% |
| 2018-06-30 | AU$2.95 Million ≈ $2.09 Million |
+15.91% |
| 2017-06-30 | AU$2.55 Million ≈ $1.80 Million |
+45.46% |
| 2016-06-30 | AU$1.75 Million ≈ $1.24 Million |
+42.74% |
| 2015-06-30 | AU$1.23 Million ≈ $867.67K |
-31.35% |
| 2014-06-30 | AU$1.79 Million ≈ $1.26 Million |
-27.19% |
| 2013-06-30 | AU$2.45 Million ≈ $1.74 Million |
+14.00% |
| 2012-06-30 | AU$2.15 Million ≈ $1.52 Million |
+26.54% |
| 2011-06-30 | AU$1.70 Million ≈ $1.20 Million |
-56.17% |
| 2010-06-30 | AU$3.88 Million ≈ $2.75 Million |
+287.84% |
| 2009-06-30 | AU$1.00 Million ≈ $707.85K |
-60.72% |
| 2008-06-30 | AU$2.55 Million ≈ $1.80 Million |
+138.67% |
| 2007-06-30 | AU$1.07 Million ≈ $755.11K |
-44.69% |
| 2006-06-30 | AU$1.93 Million ≈ $1.37 Million |
+5.72% |
| 2005-06-30 | AU$1.82 Million ≈ $1.29 Million |
+256.95% |
| 2004-06-30 | AU$511.27K ≈ $361.76K |
-41.90% |
| 2003-12-31 | AU$880.00K ≈ $622.66K |
+180.76% |
| 2003-06-30 | AU$313.44K ≈ $221.78K |
-43.93% |
| 2002-12-31 | AU$559.00K ≈ $395.53K |
+6.36% |
| 2002-06-30 | AU$525.57K ≈ $371.88K |
+1351.65% |
| 2001-06-30 | AU$36.21K ≈ $25.62K |
-58.71% |
| 2000-06-30 | AU$87.69K ≈ $62.05K |
+342.35% |
| 1999-06-30 | AU$19.82K ≈ $14.03K |
+4.35% |
| 1998-06-30 | AU$19.00K ≈ $13.44K |
-61.80% |
| 1997-06-30 | AU$49.74K ≈ $35.19K |
-41.90% |
| 1996-06-30 | AU$85.60K ≈ $60.57K |
-64.52% |
| 1995-06-30 | AU$241.24K ≈ $170.70K |
-36.85% |
| 1994-06-30 | AU$381.99K ≈ $270.29K |
-- |
About Avita Medical Inc
AVITA Medical, Inc., together with its subsidiaries, operates as a therapeutic acute wound care company in the United States, Japan, the European Union, Australia, and the United Kingdom. The company's lead product is the RECELL System, a cell harvesting device used for the treatment of thermal burn wounds and full-thickness skin defects, as well as for repigmentation of stable depigmented vitili… Read more